# Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms

> **NCT02150369** · — · COMPLETED · sponsor: **Duke University** · enrollment: 32 (actual)

## Conditions studied

- Metastatic Renal Cell Carcinoma
- Metastatic Melanoma
- High-dose Interleukin-2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02150369
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-16
- **Primary completion:** 2017-03-02
- **Final completion:** 2017-03-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02150369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02150369, "Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02150369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*